Tenax Therapeutics Inc (TENX)

NASDAQ
Currency in USD
7.0700
-0.1300(-1.81%)
Closed
TENX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
6.91607.4000
52 wk Range
2.77007.8900
Key Statistics
Edit
Prev. Close
7.2
Open
7.4
Day's Range
6.916-7.4
52 wk Range
2.77-7.89
Volume
15.1K
Average Volume (3m)
51.43K
1-Year Change
70.36%
Book Value / Share
28.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TENX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
16.3000
Upside
+130.55%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period
Show more

Tenax Therapeutics Inc Company Profile

Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Compare TENX to Peers and Sector

Metrics to compare
TENX
Peers
Sector
Relationship
P/E Ratio
−1.7x−2.8x−0.7x
PEG Ratio
−0.02−0.050.00
Price/Book
0.2x3.4x2.6x
Price / LTM Sales
-8.7x3.1x
Upside (Analyst Target)
122.2%101.0%49.4%
Fair Value Upside
Unlock13.9%8.9%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.3000
(+130.55% Upside)

Earnings

Latest Release
Apr 03, 2023
EPS / Forecast
-1.24 / -182.40
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Tenax Therapeutics (TENX) Stock Price Today?

The Tenax Therapeutics stock price today is 7.07

What Stock Exchange Does Tenax Therapeutics Trade On?

Tenax Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Tenax Therapeutics?

The stock symbol for Tenax Therapeutics is "TENX."

What Is the Tenax Therapeutics Market Cap?

As of today, Tenax Therapeutics market cap is 24.75M.

What is Tenax Therapeutics Earnings Per Share?

The Tenax Therapeutics EPS is -2.32.

From a Technical Analysis Perspective, Is TENX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.